Scarica l'app Stockscreener
0.00
100.00%
-0.6063
Precedente Chiudi:
$0.6063
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$82.91M
Reddito:
$247.99M
Utile/perdita netta:
$-521.97M
Rapporto P/E:
0.00
EPS:
-1.11
Flusso di cassa netto:
$-194.28M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$7.88
23 Andme Holding Co Stock (ME) Company Profile
Nome
23 Andme Holding Co
Settore
Industria
Telefono
(650) 938-6300
Indirizzo
223 N. MATHILDA AVE., SUNNYVALE
Confronta ME con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ME
23 Andme Holding Co
|
0.00 | 82.91M | 247.99M | -521.97M | -194.28M | -1.11 |
|
TMO
Thermo Fisher Scientific Inc
|
466.44 | 174.85B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
196.74 | 141.13B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
675.75 | 43.07B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.54 | 32.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
182.49 | 31.02B | 15.50B | 1.33B | 2.16B | 7.34 |
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-11-29 | Iniziato | Berenberg | Buy |
| 2022-09-22 | Iniziato | Cowen | Outperform |
| 2021-11-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-08-17 | Iniziato | Credit Suisse | Outperform |
| 2021-07-12 | Iniziato | Citigroup | Buy |
23 Andme Holding Co Borsa (ME) Ultime notizie
Judge OKs sale of 23andMe in bankruptcy case - MSN
WilmerHale Can Advise 23andMe Ch. 11 Data Ombudsman - Law360
23andMe Ombudsman Beats DOJ Pushback in Bid to Hire WilmerHale - Bloomberg Law News
House Bill Would Close Privacy Loophole Exposed by 23andMe Bankruptcy (Jul 18, 2025) - VitalLaw.com
23andMe Bankruptcy Update: How the Proceedings Highlight Best Practices for Handling and Transferring Genetic Data and Personal Information - Foley Hoag
23andMe data breach class action settlement - Class Action Lawsuits
Lam Research Corporation shares rise 1.72% premarket after TTAM Research Institute completed acquisition of 23andMe Holding Co. - AInvest
23andMe Co-Founder Anne Wojcicki Wins Back Company In $305M Deal, Beating Regeneron’s Bid - MSN
23andMe Holding says debtors repay all outstanding indebtedness, terminate loan agreement - MarketScreener
23andMe Completes Asset Sale Amid Bankruptcy - TipRanks
Press Release: TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets - 富途牛牛
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets - The Manila Times
23andMe Founder Saves DNA Testing Service: Nonprofit TTAM Takes Over Customer Data and Research - Stock Titan
23andMe sale approved by judge in bankruptcy case - MSN
23andMe Sale to Proceed as California Continues Appeal (Correct) - Bloomberg Law News
WilmerHale, US Trustee Spar Over Work In 23andMe Ch. 11 - Law360
US judge won't block 23andMe bankruptcy sale to co-founder - Reuters
Judge briefly pauses 23andMe bankruptcy sale amid California's appeal - Reuters
23andMe Privacy Reviewer Defends WilmerHale as Choice of Counsel - Bloomberg Law News
Calif. Fails To Pause 23andMe's Sale During Appeal - Law360
California fails to stop 23andMe founder from re-acquiring company - Reuters
Court quashes appeal relating to 23andMe’s insolvency after global data breach - Law360 Canada
California Appeals 23andMe Genetic Data Sale in Bankruptcy Case - Bloomberg Law News
The Former CEO of 23andMe Bought the Company Back, and I'm Tentatively Optimistic - Lifehacker
Judge approves 23andMe sale - The San Joaquin Valley Sun
Judge approves sale of genetics company 23andMe to founder’s nonprofit group - Washington Times
Judge OKs 23AndMe's $305M Genetic Data Asset Sale - Law360
23andMe wins court OK for $305M asset sale; equity risk flagged | ME SEC FilingForm 8-K - Stock Titan
23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation - GlobeNewswire
23andMe's Massive $305M Transformation: Founder Returns to Lead New Nonprofit Future - Stock Titan
23 Andme Holding Co Azioni (ME) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.17%
1.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):